Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group study A5267

BACKGROUND: Drug-drug interactions complicate management of co-infection with HIV-1 and Mycobacterium tuberculosis. Bedaquiline (formerly TMC207), an investigational agent for the treatment of tuberculosis, is metabolized by cytochrome P450 (CYP) 3A which may be induced by the antiretroviral drug ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dooley, Kelly E, Park, Jeong-Gun, Swindells, Susan, Allen, Reena, Haas, David W., Cramer, Yoninah, Aweeka, Francesca, Wiggins, Ilene, Gupta, Amita, Lizak, Patricia, Qasba, Sonia, van Heeswijk, Rolf, Flexner, Charles
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3302922/
https://ncbi.nlm.nih.gov/pubmed/22126739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e3182410503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados